Healthcare Healthtech & Medtech M&A Transactions

Nazca Capital in exclusive negotiations for Aldous Bio, a Spanish nutritional supplement firm. Deal highlights growth in the health and wellness sector.

THL Partners acquires Celerion Holdings for $1.8 billion. H.I.G. Capital exits its investment in the drug development services provider.

Sensei Biotherapeutics

Faeth Therapeutics, formerly Sensei Biotherapeutics, begins trading with $200M, advancing its novel PIKTOR oral oncology therapy.

THL Partners acquires Celerion, a specialized clinical pharmacology CRO, for $1.8 billion from H.I.G. Capital. Learn about this major deal in pharma services.

Thoreau Group, backed by Apollo Global Management, is nearing a $12 billion acquisition of Ensemble Health Partners, a key player in healthcare revenue cycle management.

Sigma Healthcare

Sigma Healthcare halts discussions for a potential $10B acquisition of Boots, prioritizing domestic growth and strategic alignment.

Med-Metrix strengthens its revenue cycle capabilities by acquiring CanAide, focusing on Medicaid eligibility and enrollment automation for healthcare providers.

Ignite Proteomics to go public through a $150M business combination with Copley Acquisition Corp, enhancing precision oncology diagnostics.

Spectrum Vascular enhances its vascular access offerings by acquiring Piccolo Medical and its innovative catheter guidance technology. Learn more about the strategic deal.

Teva Pharmaceutical Industries completes $700M acquisition of Emalex Biosciences, gaining promising Tourette syndrome drug ecopipam and advancing growth strategy.

Scholl's strengthens its market position by acquiring VKTRY, integrating innovative performance insoles and athletic footwear technology into its portfolio.

Otsuka America acquires Transcend Therapeutics for $700M, enhancing its CNS disorder treatment pipeline, particularly for PTSD. Learn more about this strategic deal.

Sagility integrates CareSeed's analytics and HEDIS reporting to boost AI-driven quality operations and Medicare Advantage solutions for health plans.

Medtronic strengthens its neurovascular portfolio by acquiring Scientia Vascular for $550M, integrating advanced access technologies to improve stroke and aneurysm treatments.

Merrithew strengthens its global mind-body fitness leadership by acquiring the GYROTONIC Organization, enhancing its educational and equipment offerings.

Senior Sistemas buys Brazilian healthtech leader Salú for $58.7M, enhancing its HR and employee management offerings with occupational health solutions.

Chariot Capital Group finalizes acquisition of Laser Clinics UK, a top aesthetics provider, to drive expansion and enhance its market position.

Aditxt

Ignite Proteomics valued at $150M in strategic spin-off from Aditxt. The precision oncology firm aims for enhanced growth and market visibility as an independent public entity.

Ceva Animal Health strengthens its swine intestinal health offerings by acquiring Aquilón CyL S.L., a Spanish biotech firm specializing in disease prevention and reduced antibiotic use.

PartsSource enhances its clinical technology platform with SkillNet acquisition, boosting workforce intelligence for healthcare asset management and operational efficiency.

Sycamore Partners is reportedly evaluating a $10 billion divestiture of its UK health and beauty chain, Boots, drawing interest from global players.

Healthcare Holding Schweiz AG, backed by Winterberg Advisory and KKA Partners, has acquired Compet Medical AG, enhancing its medical technology portfolio in harm reduction.

Novanta Inc. buys Riverpoint Medical for $1.45B, enhancing its medical device capabilities. Arlington Capital Partners achieves a successful exit.

Boots

Sycamore Partners considers a $10 billion sale of Boots, moving away from a London Stock Exchange listing. Key bidders emerge in a dynamic retail market.

GSK's $10.6 billion acquisition of Nuvalent adds promising targeted lung cancer therapies, enhancing its oncology leadership and precision medicine capabilities.

GSK strengthens its oncology portfolio by acquiring Nuvalent for $10.6 billion, focusing on precision therapies for non-small cell lung cancer.

AMN Healthcare enhances patient communication by acquiring Jaide Health, integrating AI and human interpreters for comprehensive language access in healthcare.

EMS secures Medley for $600 million, bolstering its position in Brazil's generics sector. Deal faces Cade review amid market competition analysis.

Gilead Sciences and Lakefront Biotherapeutics secure Ouro Medicines' autoimmune asset for $1.675B, advancing T cell engager therapies for immune disorders.

Johnson & Johnson secures Firefly Bio for $1 billion, boosting its oncology pipeline with advanced degrader antibody conjugate technology for difficult-to-treat cancers.

Egyptian firm Edafa Venture expands AI focus with strategic acquisitions of construction tech innovator Kuadra and health diagnostics specialist IRRI Vision.

Elsevier enhances clinical decision support by acquiring Wellsheet, merging patient data with AI-driven evidence for healthcare professionals.

China's Aier Eye Hospital Group acquires a significant stake in Brazil's Opty, injecting capital for expansion and marking a major cross-border healthcare deal.

Elation Health acquires Aster to boost its AI technology, advancing its vision for an agentic operating system designed to automate tasks for primary care providers.

LaserAway

Ares-backed LaserAway is reportedly considering a sale exceeding $2 billion, highlighting robust investor interest in the thriving medical spa and dermatology market.

Revenio Group's EUR 290M acquisition of Visionix International creates a leading independent provider of advanced eye care diagnostics and imaging solutions.

Prevenzione e Salute Holding

Prevenzione e Salute Holding, backed by Armònia sgr, acquires Sky Dental, expanding its healthcare network to 57 centers and targeting growth in the dental sector.

Photocure ASA strengthens its bladder cancer diagnostics leadership by acquiring Vesica Health Inc. for $30.5M, enhancing early detection with AssureMDx.

China National Pharmaceutical secures EdiBio for $1.654 billion in a strategic move to enhance its oncology companion diagnostics and precision medicine offerings.

ProA Capital strengthens Grupo Life Dental's market position through the acquisition of DAS operations, highlighting growth in Spain's dental services sector.